COPN fundamentals
COSMO PHARMACEUTICALS NV financial statements, including revenue, expenses, profit, and loss
The total revenue of COPN for the last semiannual is 136.04 M EUR, and it's 168.76% higher compared to the previous semiannual. The net income of H1 24 is 75.88 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM